The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSenior Regulatory News (SNR)

Share Price Information for Senior (SNR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 165.00
Bid: 164.40
Ask: 165.00
Change: 0.60 (0.36%)
Spread: 0.60 (0.365%)
Open: 165.20
High: 165.40
Low: 163.80
Prev. Close: 164.40
SNR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - SENIOR PLC

25 Jun 2021 12:49

 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a)Full name of discloser:

Barclays PLC.

 
(b)Owner or controller of interest and short

 

positions disclosed, if different from 1(a):
(c)Name of offeror/offeree in relation to whose

SENIOR PLC

relevant securities this form relates:
(d)If an exempt fund manager connected with an

 

offeror/offeree, state this and specify identity of
offeror/offeree:
(e)Date position held/dealing undertaken:

24 June 2021

(f)In addition to the company in 1(c) above, is the discloser making

NO

disclosures in respect of any other party to the offer?

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:10p ordinary

Interests

Short Positions

Number

(%)

Number

(%)

(1)

Relevant securities owned

 

 

 

 

and/or controlled:

5,599,322

1.34%

503,951

0.12%

 

 

 

 

(2)

Cash-settled derivatives:

 

 

 

 

458,190

0.11%

3,020,041

0.72%

 

 

 

 

(3)

Stock-settled derivatives (including options)

 

 

 

 

and agreements to purchase/sell:

0

0.00%

0

0.00%

 

 

 

 

 

 

 

 

TOTAL:

6,057,512

1.44%

3,523,992

0.84%

 

 

 

 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant

Purchase/sale

Number of

Price per unit

security

 

securities

 

10p ordinary

Purchase

14

1.4959 GBP

10p ordinary

Purchase

585

1.5090 GBP

10p ordinary

Purchase

1,000

1.5050 GBP

10p ordinary

Purchase

2,856

1.5051 GBP

10p ordinary

Purchase

7,020

1.5068 GBP

10p ordinary

Purchase

7,228

1.4966 GBP

10p ordinary

Purchase

9,010

1.4960 GBP

10p ordinary

Purchase

45,526

1.5060 GBP

10p ordinary

Purchase

95,801

1.5026 GBP

10p ordinary

Sale

604

1.5130 GBP

10p ordinary

Sale

866

1.5129 GBP

10p ordinary

Sale

1,706

1.5050 GBP

10p ordinary

Sale

2,000

1.5038 GBP

10p ordinary

Sale

2,077

1.5020 GBP

10p ordinary

Sale

2,671

1.5043 GBP

10p ordinary

Sale

2,753

1.5079 GBP

10p ordinary

Sale

3,297

1.5060 GBP

10p ordinary

Sale

6,615

1.5084 GBP

10p ordinary

Sale

6,619

1.5076 GBP

10p ordinary

Sale

7,274

1.4961 GBP

10p ordinary

Sale

8,141

1.5032 GBP

10p ordinary

Sale

24,567

1.5069 GBP

10p ordinary

Sale

41,548

1.5063 GBP

(b) Cash-settled derivative transactions

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

 

reference

unit

security

 

 

securities

 

10p ordinary

CFD

Long

5

1.5240 GBP

10p ordinary

SWAP

Long

750

1.4888 GBP

10p ordinary

SWAP

Long

2,000

1.5038 GBP

10p ordinary

CFD

Long

2,900

1.5060 GBP

10p ordinary

SWAP

Long

5,849

1.5077 GBP

10p ordinary

SWAP

Long

16,048

1.5015 GBP

10p ordinary

SWAP

Long

26,075

1.5101 GBP

10p ordinary

SWAP

Short

3,010

1.5096 GBP

10p ordinary

SWAP

Short

3,577

1.4960 GBP

10p ordinary

SWAP

Short

5,179

1.5107 GBP

10p ordinary

CFD

Short

10,423

1.5060 GBP

10p ordinary

SWAP

Short

12,226

1.4988 GBP

10p ordinary

SWAP

Short

36,388

1.5011 GBP

10p ordinary

SWAP

Short

37,195

1.5041 GBP

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

 

 

 

 

 

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO
Date of disclosure:

25 Jun 2021

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210625005239/en/

Copyright Business Wire 2021

Date   Source Headline
29th Apr 20246:15 pmRNSDirector/PDMR Shareholding
26th Apr 20242:18 pmRNSResult of AGM
26th Apr 20247:00 amRNSSenior plc - Q1 2024 Trading Update
25th Apr 20247:00 amRNSSenior plc - Contract extension with Spirit
25th Mar 20244:55 pmRNSHolding(s) in Company
21st Mar 202411:22 amRNSVesting of share awards
15th Mar 20244:20 pmRNSGrant of Executive Share Awards
8th Mar 202411:12 amRNSSenior plc 2023 Annual Report and Notice of AGM
4th Mar 20247:00 amRNSSenior plc - 2023 Annual Results
29th Feb 20244:17 pmRNSBlock listing Interim Review
21st Feb 20247:00 amRNSSenior plc announces contract awards from Airbus
6th Feb 20248:00 amRNSSenior plc on CDP 2023 Climate Change ‘A List’
5th Dec 20237:00 amRNSSenior plc announces contract award from Strata
20th Nov 20237:00 amRNSTrading Update
9th Nov 202310:00 amRNSAppointment of Non-executive Director
26th Oct 20237:00 amRNSSenior plc announces Battery Cooling Plates order
13th Oct 20237:00 amRNSSenior achieves SBTi net-zero target designation
2nd Oct 20232:56 pmRNSDirector/PDMR Shareholding
27th Sep 20237:00 amRNSSenior announces multi-year Rolls-Royce contract
31st Aug 202310:00 amRNSBlock listing Interim Review
15th Aug 20235:10 pmRNSHolding(s) in Company
31st Jul 20237:00 amRNSHalf-year Report
18th Jul 20239:07 amRNSHolding(s) in Company
14th Jul 20232:45 pmRNSHolding(s) in Company
12th Jun 20235:52 pmRNSHolding(s) in Company
8th Jun 20235:15 pmRNSAppointment of Joint Corporate Broker
25th May 202312:25 pmRNSDirector Declaration
9th May 20237:00 amRNSDirector/PDMR Shareholding
27th Apr 20234:19 pmRNSHolding(s) in Company
26th Apr 202311:33 amRNSDirector/PDMR Shareholding
21st Apr 20235:28 pmRNSResult of AGM
20th Apr 20234:35 pmRNSDirector Declaration
20th Apr 20237:00 amRNSTrading Update Q1 2023
24th Mar 20233:26 pmRNSAnnual Financial Report
22nd Mar 20239:00 amRNSChange to Director's Details
15th Mar 20234:19 pmRNSSenior awarded leadership status rating by CDP
14th Mar 20235:22 pmRNSGrant of Executive Share Awards
14th Mar 20235:11 pmRNSHolding(s) in Company
9th Mar 20235:58 pmRNSDirector/PDMR Shareholding
2nd Mar 20235:59 pmRNSHolding(s) in Company
1st Mar 202312:05 pmRNSBlock listing Interim Review
1st Mar 202311:56 amRNSHolding(s) in Company
27th Feb 20237:00 amRNSFinal Results
24th Jan 20237:00 amRNSFY22 Post-close Trading Update
18th Jan 20235:11 pmRNSHolding(s) in Company
13th Jan 20236:12 pmRNSAveva Group
19th Dec 20223:35 pmRNSDirector/PDMR Shareholding
15th Dec 20229:58 amRNSHolding(s) in Company
13th Dec 20225:52 pmRNSSenior awarded ‘A’ for climate change transparency
9th Dec 202210:12 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.